These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28238951)

  • 1. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.
    Neil S; Huh J; Baronas V; Li X; McFarland HF; Cherukuri M; Mitchell JB; Quandt JA
    Brain Behav Immun; 2017 May; 62():332-343. PubMed ID: 28238951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
    Wen J; Ariyannur PS; Ribeiro R; Tanaka M; Moffett JR; Kirmani BF; Namboodiri AM; Zhang Y
    J Neuroimmune Pharmacol; 2016 Dec; 11(4):763-773. PubMed ID: 27562847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brain barrier, reducing viral load, and lessening inflammation.
    Tsuhako MH; Augusto O; Linares E; Chadi G; Giorgio S; Pereira CA
    Free Radic Biol Med; 2010 Mar; 48(5):704-12. PubMed ID: 20035861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
    Yang EJ; Song IS; Song KS
    Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
    Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of new therapeutic targets for prevention of CNS inflammation.
    Owens T
    Expert Opin Ther Targets; 2002 Apr; 6(2):203-15. PubMed ID: 12223081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
    Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L
    Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
    Savarin C; Hinton DR; Valentin-Torres A; Chen Z; Trapp BD; Bergmann CC; Stohlman SA
    J Neuroinflammation; 2015 Apr; 12():79. PubMed ID: 25896970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
    J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
    Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease.
    Liang Q; Smith AD; Pan S; Tyurin VA; Kagan VE; Hastings TG; Schor NF
    Biochem Pharmacol; 2005 Nov; 70(9):1371-81. PubMed ID: 16144694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.